Physician profile
Arvind Reddy Devanabanda
NPI 1578974069
$33,976.24
in general payments reported to CMS, 2019-2025
24 companies · $3,014 in 2025
The $3,014 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $273 · 2021: $9,245 · 2022: $8,186 · 2023: $4,527 · 2024: $8,731 · 2025: $3,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,275 · Travel and Lodging: $7,567 · Consulting Fee: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,275.15 |
| Travel and Lodging | $7,567.02 |
| Consulting Fee | $430.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15,598.96 | 2021-2025 | Optis, Perclose Proglide, Xact |
| Medtronic, INC. | $5,945.14 | 2021-2025 | Turbohawk, Abre, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $5,941.23 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| W. L. Gore & Associates, INC. | $1,864.57 | 2022-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis |
| Boston Scientific Corporation | $1,448.41 | 2021-2025 | Watchman Access System, Synergy, Rotapro |
| Penumbra, INC. | $1,312.09 | 2023-2024 | Indigo System |
| Novartis Pharmaceuticals Corporation | $367.31 | 2022-2025 | |
| Inari Medical, INC. | $285.55 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $272.82 | 2020 | |
| Amgen INC. | $186.13 | 2021-2025 | Repatha |
| Teleflex LLC | $161.52 | 2022-2025 | Manta |
| Bard Peripheral Vascular, INC. | $100.00 | 2023 | |
| Zoll Circulation INC | $99.80 | 2023-2025 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Lemaitre Vascular, INC. | $65.31 | 2024-2025 | Artegraft Vascular Graft |
| Livanova USA, INC. | $53.08 | 2022-2023 | Lifesparc |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $50.15 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.54 | 2022-2025 | Lifevest |
| Heartflow, INC. | $45.99 | 2025 | |
| Pfizer INC. | $45.34 | 2023-2024 | |
| Angiodynamics, INC. | $19.79 | 2023 | Angiovac |
| Abiomed | $19.50 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.95 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.15 | 2021 | |
| Cordis US Corp. | $13.91 | 2024 | Precise Pro Rx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvind Reddy Devanabanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.